Robot-assisted nephroureterectomy: current perspectives

open access

Conclusion

RALNU has emerged as a novel minimally invasive alternative to laparoscopic and open NU and has demonstrated promising early results. With experience and progress in the technology of the da Vinci robotic system, the need for intraoperative redocking or repositioning of the patients is reduced. However, RALNU is still lacking long-term reports on perioperative and oncological outcomes, even though intermediate outcomes and analyses have shown oncological equivalency when compared to other approaches. Cost efficacy studies and quality of life analysis are required to justify the higher non-negligible costs associated with RALNU.